These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. McAdam KP; Anders RF; Smith SR; Russell DA; Price MA Lancet; 1975 Sep; 2(7935):572-3. PubMed ID: 51405 [TBL] [Abstract][Full Text] [Related]
5. Erythema nodosum leprosum in a general hospital. Rea TH; Levan NE Arch Dermatol; 1975 Dec; 111(12):1575-80. PubMed ID: 1106330 [TBL] [Abstract][Full Text] [Related]
11. The relationship of dapsone (DDS) therapy to erythema nodosum leprosum. Is it direct or indirect? Waters MF; Helmy HS Lepr Rev; 1974 Dec; 45(4):299-307. PubMed ID: 4613978 [No Abstract] [Full Text] [Related]
12. The management of leprosy and its complications. Trautman JR N Engl J Med; 1965 Sep; 273(14):756-8. PubMed ID: 5825688 [No Abstract] [Full Text] [Related]
13. The etiology of erythema nodosum leprosum. Pettit JH; Waters MF Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035 [No Abstract] [Full Text] [Related]
20. Secondary amyloidosis and the serum amyloid precursor in leprosy: geographical variation and association with leukocytosis. McAdam KP; Anders RF; Aiken G; Takitaki FF Int J Lepr Other Mycobact Dis; 1977; 45(2):150-7. PubMed ID: 561759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]